Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2015 Volume 12 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2015 Volume 12 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Involvement of the Wnt signaling pathway in feeder‑free culture of human induced pluripotent stem cells

  • Authors:
    • Minoru Tomizawa
    • Fuminobu Shinozaki
    • Yasufumi Motoyoshi
    • Takao Sugiyama
    • Shigenori Yamamoto
    • Naoki Ishige
  • View Affiliations / Copyright

    Affiliations: Department of Gastroenterology, National Hospital Organization, Shimoshizu Hospital, Yotsukaido, Chiba 284‑0003, Japan, Department of Radiology, National Hospital Organization, Shimoshizu Hospital, Yotsukaido, Chiba 284‑0003, Japan, Department of Neurology, National Hospital Organization, Shimoshizu Hospital, Yotsukaido, Chiba 284‑0003, Japan, Department of Rheumatology, National Hospital Organization, Shimoshizu Hospital, Yotsukaido, Chiba 284‑0003, Japan, Department of Pediatrics, National Hospital Organization, Shimoshizu Hospital, Yotsukaido, Chiba 284‑0003, Japan, Department of Neurosurgery, National Hospital Organization, Shimoshizu Hospital, Yotsukaido, Chiba 284‑0003, Japan
  • Pages: 6797-6800
    |
    Published online on: September 10, 2015
       https://doi.org/10.3892/mmr.2015.4314
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Activin A maintains the pluripotency of human induced pluripotent stem (hiPS) cells. A combination of activin A and CHIR99021 (CHIR), a specific inhibitor of glycogen synthase‑3β, is suitable for feeder‑free culture of hiPS cells. In the present study, the specific role of the Wnt signaling pathway in cells cultured under different conditions was investigated. Following transfection with the reporter plasmids, TOPflash and FOPflash, hiPS cells were cultured in medium, containing activin A, CHIR, leukemia inhibitory factor (LIF) or SB431542, a specific inhibitor of activin A. A luciferase reporter assay was performed 48 h later. Western blot analysis was performed to determine the expression levels of β‑catenin and tubulin‑α. The activity of Wnt in hiPS cells was suppressed by culture in the presence of activin A. The activation of the Wnt pathway was most marked when the cells were cultured with a combination of activin A and CHIR. Addition of SB431542 into the culture revealed no significant change in the Wnt pathway. Western blot analysis revealed that β‑catenin accumulated most often in cells cultured with activin A and CHIR. β‑catenin also accumulated in cells cultured with activin A alone. Culture with activin A and CHIR most effectively stimulated the Wnt signaling pathway, as measured by luciferase assays using TOPflash and FOP flash as reporter plasmids. β‑catenin accumulated in the hiPS cells cultured with activin A, via a mechanism, which remains to be elucidated. The Wnt signaling pathway may be important for hiPS cell growth in feeder‑free culture.

Introduction

Human induced pluripotent stem (hiPS) cells are a promising cell source for regenerative medicine. To avoid exposure of hiPS cells to proteins from species other than human, feeder-free culture conditions have been developed (1). Several factors have been identified, which are part of the signaling network of hiPS cells (2). Leukemia inhibitory factor (LIF) is involved in the pluripotency of mouse embryonic stem cells (3). In human embryonic stem (hES) cells, Nodal/activin A is involved in pluripotency (3). Activin A maintains the pluripotency of hiPS cells under feeder-free conditions by regulating the expression of Nanog (4–6). Basic fibroblast growth factor (bFGF) sustains the self-renewal capacity of hES cells (7). CHIR99021 (CHIR), a glycogen synthase kinase (GSK)-3β inhibitor, improves the ability of hiPS cells to maintain pluripotency by acting synergistically with activin A (8). The development of hiPS cells from human embryonic keratinocytes via the activation of Oct3/4 and Klf4 was reported to be driven by culture with CHIR (9). Mouse iPS cells can also be generated in culture medium containing Oct3/4 and CHIR (10). Finally, mouse embryonic stem cells maintain pluripotency when cultured with CHIR (11). Taken together, these reports suggest that CHIR is involved in the maintenance of pluripotency. Since GSK-3β is involved in the activation of the Wnt signaling pathway, it is likely that the Wnt pathway is important in pluripotency (12).

The Wnt signaling pathway is mediated by Disheveled (Dsh) proteins in Xenopus. Dsh proteins inhibit GSK-3β and promote the accumulation of β-catenin. Dsh homolog (Dvl)2, a mammalian homolog of Dsh, is phosphorylated upon stimulation by the Wnt signaling pathway and mediates endocytosis of the frizzled receptor (13,14). Once GSK-3β has been inactivated via phosphorylation of Ser9 by Dvl2, β-catenin accumulates in the cytoplasm and subsequently translocates into the nucleus (15).

The role of the Wnt signaling pathway in hiPS cells is controversial. The Wnt signaling pathway has been demonstrated to be involved in pluripotency (16) and accumulation of β-catenin by inhibition of GSK-3β sustains pluripotency in conjunction with other factors (17). Indeed, the addition of the GSK-3β inhibitor to the culture facilitates the efficient generation of hiPS cells (18). On the other hand, the Wnt signaling pathway has been demonstrated to promote the differentiation of hiPS cells in conjunction with other factors. For instance, stage-specific activation of bone morphogenetic protein and the Wnt signaling pathway promotes the differentiation of iPS cells into epicardial cells (19). The combination of the Wnt signaling pathway and bFGF promotes the differentiation of iPS cells into nephron progenitor cells (20). Therefore, the present study investigated the direct role of the Wnt signaling pathway in maintaining hiPS pluripotency under feeder-free culture conditions (8).

Materials and methods

Cell culture

The hiPS cells (201B7; Riken Cell Bank, Tsukuba, Japan) were cultured in 6-well plates (Asahi Techno Glass, Tokyo, Japan) coated with Matrigel™ (Becton Dickinson, Franklin Lakes, NJ, USA) in ReproFF medium (Reprocell, Yokohama, Japan) for feeder-free culture in 5% CO2 at 37°C in a humidified chamber. The cells were harvested using Accutase® (Innovative Cell Technologies, Inc., San Diego, CA, USA) for experiments. A total of 10 ng/ml activin A (R&D Systems, Inc., Minneapolis, MN, USA), 2 µM GSK-3β inhibitor (CHIR; Wako Pure Chemicals Industries, Ltd., Osaka, Japan), 1,000 U/ml human LIF (Sigma-Aldrich, St. Louis, MO, USA) or the SB431542 activin A inhibitor (Wako Pure Chemicals Industries, Ltd.) was added to Dulbecco's Minimum Essential Medium-F12 (Sigma-Aldrich), supplemented with 20% Knockout Serum Replacement (Life Technologies, Grand Island, NY, USA), 10% Minimum Essential Amino Acids (Life Technologies), 2 mM l-Glutamine (Life Technologies), and 1 mM 2-Mercaptoethanol [iPSm(-); Sigma-Aldrich].

Luciferase assay

The 201B7 cells were seeded into 24-well plates, coated with Matrigel™, and cultured for 24 h. Once the cells reached 70% confluence, they were transfected with Lipofectamine LTX (Life Science Technologies), and 0.5 µg TOPflash reporter plasmid or FOPflash reporter plasmid (EMD Millipore, Temecula, CA, USA) and 0.05 µg pRL-TK (Promega, Madison, WI, USA) was added to the medium. The transcriptional activity was measured using a dual luciferase reporter assay system (Promega) using Gene Light (GL-200A; Microtech Co. Ltd., Funabashi, Japan). Non-transfected cells were used as a negative control. The ratio of the luciferase activity of TOPflash against that of FOPflash was calculated. The relative Wnt activity was determined by normalizing this ratio against that of 201B7 cells cultured in ReproFF medium.

Western blot analysis

The total protein was isolated from the cells following culture for 48 h. A 10 µg protein sample was separated on 12 %sodium dodecyl sulfate (Wako Pure Chemicals Industries, Ltd.)-polyacrylamide (Bio-Rad, Hercules, CA, USA) gel electrophoresis gels and was subsequently transferred to a nylon filter (EMD Millipore). Following blocking for 30 min with 5% non-fat milk, the filters were incubated with rabbit monoclonal anti-human β-catenin antibodies (1:2,500; cat. no. #9582; Cell Signaling Technology, Inc., Danvers, MA, USA) for 1 h at room temperature. The filters were washed in phosphate-buffered saline (PBS) three times, and subsequently incubated with horseradish peroxidase (HRP)-conjugated anti-rabbit antibody (1:2,500; cat. no. NA934-100UL; GE Healthcare Life Sciences, Little Chalfont, UK) at room temperature for 1 h. After three washes with PBS, the specific antigen-antibody complexes were visualized using enhanced chemiluminescence (cat. no. RPN2232; GE Healthcare Life Sciences). The filter was reprobed with 10 Minute Western Re-probe kit (cat. no. JZ-008; Jacksun Easy Biotech Inc., New York, NY, USA), and incubated with mouse monoclonal anti-human α-tubulin antibody (cat. no. MS-581-P0; 1:2,500; Lab Vision Corporation, Fremont, CA, USA) for 1 h to use as a loading control. The filters were washed with PBS, and incubated with HRP-linked anti-mouse antibody (cat. no. NA931- 100UL; GE Healthcare Life Sciences) for 1 h. The specific antigen-antibody complexes were visualized using enhanced chemiluminescence (cat. no. RPN2232; GE Healthcare Life Sciences) after three washes with PBS. The expression levels of β-catenin were normalized against that of α-tubulin and were analyzed using ImageJ 64 imaging software (National Institutes of Health, Bethesda, MD, USA).

Statistical analysis

Statistical analysis was performed by one-factor analysis of variance using JMP 10.0.2 (SAS Institute, Cary, NC, USA). P<0.05 was considered to indicate a statistically significant difference.

Results

To investigate activity of the Wnt signaling pathway, a luciferase assay was performed using TOPflash and FOPflash as reporter plasmids (Fig. 1). Following transfection, activin A, CHIR and/or LIF was added to the cell culture medium. The relative Wnt activity was lower in the cells cultured in iPSm(-) (0.18±0.05; P<0.05) compared with the ReproFF cultured cells. The addition of activin A suppressed the activity of Wnt when compared with the cells cultured in iPSm(-) alone (0.11±0.05). By contrast, the Wnt signaling pathway was markedly activated in cells cultured with activin A and CHIR (5.28±0.23; P<0.05). These results suggested that the combination of activin A and CHIR in the culture medium clearly stimulated the Wnt pathway.

Figure 1

Luciferase reporter assay. Human induced pluripotent stem cells were transfected with the reporter plasmids, TOPflash or FOPflash, cultured in various media and subjected to a luciferase reporter assay. The ratios of TOPflash/FOPflash in the transfected cells were normalized against the cells cultured with ReproFF alone, and the resulting value was expressed as the relative Wnt activity. The data are presented as the mean ± standard deviation (*P<0.05; n=3). FF, ReproFF; (-), iPSm(-); A, activin A; C, CHIR99021; L, leukemia inhibitory factor; AC, activin A + CHIR99021; ACL, activin A, CHIR99021 + leukemia inhibitory factor.

To analyze the accumulation of β-catenin, western blot analysis was performed following the addition of activin A, CHIR and/or LIF to the culture medium (Fig. 2). The signal intensity of β-catenin was divided by the intensity of tubulin-α to obtain the relative signal intensity. The relative signal intensity of β-catenin detected in cells cultured in iPSm(-) (0.94) was lower compared with that of the cells cultured in ReproFF. The relative signal intensity of β-catenin detected in the cells cultured in medium with activin A (1.80), activin A + CHIR (1.90) or the combination of activin A, CHIR + LIF (2.47) was higher compared with that detected in the cells cultured in iPSm(-) alone. These results suggested that β-catenin accumulated in response to culture with activin A and other factors.

Figure 2

Western blot analysis to determine the expression of β-catenin. The expression levels of β-catenin and tubulin-α were analyzed by western blotting. The signal intensity of β-catenin was divided by that of tubulin-α to generate the relative signal intensity, as indicated above the band lanes. The cell treatment types in each lane were as follows: 1, ReproFF; 2, iPSm(-); 3, activin A; 4, activin A + CHIR99021; 5, activin A, CHIR99021 + leukemia inhibitory factor.

To address the possibility that activin A stimulated the Wnt signaling pathway to a comparable level of ReproFF and SB431542, a specific inhibitor of activin A was added to the culture medium, and a luciferase assay was performed (Fig. 3). The relative Wnt activity was lower in the cells cultured in media containing activin A (0.28±0.11) compared with those cultured in iPSm(-) (0.49±0.27). The relative Wnt activity of the cells cultured in medium with activin A + CHIR (2.20±0.68; P<0.05) and the combination of activin A, CHIR + LIF (1.85±0.58; P<0.05) was higher compared with that in the cells cultured in ReproFF alone. These results were consistent with those shown in Fig. 1. The relative Wnt activity was lower in the cells cultured with activin A + SB431542 compared with those cultured in the presence of activin A alone. Addition of SB431542 to the culture marginally increased the relative Wnt activity simulated by culture with activin A + CHIR, and the combination of activin A, CHIR + LIF. However, these differences were non-significant.

Figure 3

Luciferase reporter assay. Human induced pluripotent stem cells transfected with the reporter plasmids, TOPflash or FOPflash, were cultured in various media and were subjected to a luciferase reporter assay. The ratios of TOPflash/FOPflash in transfected cells were normalized against the cells cultured with ReproFF alone and the resulting value was expressed as the relative Wnt activity. The data are presented as the mean ± standard deviation (*P<0.05; n=3). FF, ReproFF; (-), iPSm(-); A, activin A; A + S, activin A + SB431542; AC, activin A + CHIR99021; ACS, activin A, CHIR99021 + SB431542; ACL, activin A, CHIR99021 + leukemia inhibitory factor; ACLS, activin A, CHIR99021, leukemia inhibitory factor + SB431542.

Discussion

Activin A is essential for the maintenance of the pluripotency of hiPS cells cultured under feeder-free conditions (4,21). In our previous study, hiPS cells were cultured under feeder-free conditions in the presence of activin A and CHIR (8). Since CHIR is involved in activation of the Wnt signaling pathway, it was hypothesized that activin A and the Wnt signaling pathway cooperate to maintain the pluripotency and proliferation of iPS cells. In the present study, the relative Wnt activity and the expression of β-catenin were investigated. As expected, the relative Wnt activity was greatest in the cells cultured with a combination of activin A and CHIR. These results indicated that the activation of the Wnt signaling pathway was optimal for the feeder-free culture of iPS cells.

Unexpectedly, the cells cultured in medium, supplemented with only activin A, resulted in the accumulation of β-catenin. It was unclear why β-catenin accumulated in the culture supplemented with activin A, while the relative Wnt activity was suppressed. These results may represent crosstalk between activin A and the Wnt signaling pathway (22).

In the present study, one of the limitations was that the expression levels of GSK3β and Dvl2 remained to be determined. The expression levels of GSK3β and Dvl2 has been previously demonstrated to increase when the Wnt signaling pathway is stimulated (23). An analysis of these molecules is required to fully elucidate the mechanism underlying the activation of the Wnt signaling pathway, and future studies in our laboratory will focus on this line of research.

In conclusion, culture with medium containing activin A and CHIR stimulated the Wnt signaling pathway, as measured using a luciferase assay with the TOPflash and FOP flash reporter plasmids. The addition of activin A to the culture medium was associated with β-catenin accumulation, although the underlying mechanism remains to be elucidated. Overall, these results suggested that the Wnt signaling pathway may be required for the maintenance of pluripotency in hiPS cells cultured under feeder-free conditions.

References

1 

Meng G, Liu S and Rancourt DE: Synergistic effect of medium, matrix and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions. Stem Cells Dev. 21:2036–2048. 2012. View Article : Google Scholar

2 

Dalton S: Signaling networks in human pluripotent stem cells. Curr Opin Cell Biol. 25:241–246. 2013. View Article : Google Scholar :

3 

Dowell KG, Simons AK, Bai H, Kell B, Wang ZZ, Yun K and Hibbs MA: Novel insights into embryonic stem cell self-renewal revealed through comparative human and mouse systems biology networks. Stem Cells. 32:1161–1172. 2014. View Article : Google Scholar

4 

Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M and Yoshida T: Activin A maintains pluripotency markers and proliferative potential of human induced pluripotent stem cells. Exp Ther Med. 2:405–408. 2011.PubMed/NCBI

5 

Shin M, Alev C, Wu Y, Nagai H and Sheng G: Activin/TGF-beta signaling regulates Nanog expression in the epiblast during gastrulation. Mech Dev. 128:268–278. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Miyanari Y and Torres-Padilla ME: Control of ground-state pluripotency by allelic regulation of Nanog. Nature. 483:470–473. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Xu RH, Peck RM, Li DS, Feng X, Ludwig T and Thomson JA: Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods. 2:185–190. 2005. View Article : Google Scholar : PubMed/NCBI

8 

Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M and Yoshida T: Activin A is essential for Feeder-free culture of human induced pluripotent stem cells. J Cell Biochem. 114:584–588. 2013. View Article : Google Scholar

9 

Li W, Zhou H, Abujarour R, Zhu S, Young Joo J, Lin T, Hao E, Schöler HR, Hayek A and Ding S: Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells. 27:2992–3000. 2009.PubMed/NCBI

10 

Li Y, Zhang Q, Yin X, Yang W, Du Y, Hou P, Ge J, Liu C, Zhang W, Zhang X, et al: Generation of iPSCs from mouse fibroblasts with a single gene, Oct4 and small molecules. Cell Res. 21:196–204. 2011. View Article : Google Scholar

11 

Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J, Cohen P and Smith A: The ground state of embryonic stem cell self-renewal. Nature. 453:519–523. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Wu D and Pan W: GSK3: A multifaceted kinase in Wnt signaling. Trends Biochem Sci. 35:161–168. 2010. View Article : Google Scholar :

13 

Itoh K, Brott BK, Bae GU, Ratcliffe MJ and Sokol SY: Nuclear localization is required for Dishevelled function in Wnt/beta-catenin signaling. J Biol. 4:32005. View Article : Google Scholar : PubMed/NCBI

14 

Chen W, ten Berge D, Brown J, Ahn S, Hu LA, Miller WE, Caron MG, Barak LS, Nusse R and Lefkowitz RJ: Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science. 301:1391–1394. 2003. View Article : Google Scholar : PubMed/NCBI

15 

McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Sokolosky M, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, et al: GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. 5:2881–2911. 2014. View Article : Google Scholar : PubMed/NCBI

16 

Holland JD, Klaus A, Garratt AN and Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Sineva GS and Pospelov VA: β-Catenin in pluripotency: Adhering to self-renewal or Wnting to differentiate? Int Rev Cell Mol Biol. 312:53–78. 2014. View Article : Google Scholar

18 

Bar-Nur O, Brumbaugh J, Verheul C, Apostolou E, Pruteanu-Malinici I, Walsh RM, Ramaswamy S and Hochedlinger K: Small molecules facilitate rapid and synchronous iPSC generation. Nat Methods. 11:1170–1176. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Witty AD, Mihic A, Tam RY, Fisher SA, Mikryukov A, Shoichet MS, Li RK, Kattman SJ and Keller G: Generation of the epicardial lineage from human pluripotent stem cells. Nat Biotechnol. 32:1026–1035. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Lam AQ, Freedman BS and Bonventre JV: Directed differentiation of pluripotent stem cells to kidney cells. Semin Nephrol. 34:445–461. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Pauklin S and Vallier L: The cell-cycle state of stem cells determines cell fate propensity. Cell. 155:135–147. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Singh AM, Reynolds D, Cliff T, Ohtsuka S, Mattheyses AL, Sun Y, Menendez L, Kulik M and Dalton S: Signaling network crosstalk in human pluripotent cells: A Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell. 10:312–326. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Sueishi M and Yoshida T: Niclosamide suppresses Hepatoma cell proliferation via the Wnt pathway. Onco Targets Ther. 6:1685–1693. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S and Ishige N: Involvement of the Wnt signaling pathway in feeder‑free culture of human induced pluripotent stem cells. Mol Med Rep 12: 6797-6800, 2015.
APA
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., & Ishige, N. (2015). Involvement of the Wnt signaling pathway in feeder‑free culture of human induced pluripotent stem cells. Molecular Medicine Reports, 12, 6797-6800. https://doi.org/10.3892/mmr.2015.4314
MLA
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., Ishige, N."Involvement of the Wnt signaling pathway in feeder‑free culture of human induced pluripotent stem cells". Molecular Medicine Reports 12.5 (2015): 6797-6800.
Chicago
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., Ishige, N."Involvement of the Wnt signaling pathway in feeder‑free culture of human induced pluripotent stem cells". Molecular Medicine Reports 12, no. 5 (2015): 6797-6800. https://doi.org/10.3892/mmr.2015.4314
Copy and paste a formatted citation
x
Spandidos Publications style
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S and Ishige N: Involvement of the Wnt signaling pathway in feeder‑free culture of human induced pluripotent stem cells. Mol Med Rep 12: 6797-6800, 2015.
APA
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., & Ishige, N. (2015). Involvement of the Wnt signaling pathway in feeder‑free culture of human induced pluripotent stem cells. Molecular Medicine Reports, 12, 6797-6800. https://doi.org/10.3892/mmr.2015.4314
MLA
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., Ishige, N."Involvement of the Wnt signaling pathway in feeder‑free culture of human induced pluripotent stem cells". Molecular Medicine Reports 12.5 (2015): 6797-6800.
Chicago
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., Ishige, N."Involvement of the Wnt signaling pathway in feeder‑free culture of human induced pluripotent stem cells". Molecular Medicine Reports 12, no. 5 (2015): 6797-6800. https://doi.org/10.3892/mmr.2015.4314
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team